SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 56.68-2.4%Dec 12 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Robohogs who wrote (20582)7/24/2006 1:59:04 AM
From: tuck  Read Replies (1) of 52153
 
Hi, this is Biomaven checking in from S.A., using Tuck's account for some arcane reason of connectivity; it was free and I don't know why. Anyhow, I've narrowed it down to two: PBE and BBH.

Oh right, they're not really stocks, umm OK . . .

To avoid redundancy -- I own ARNA and PDLI, and have added to both recently (also too far into MNTA, and Mom owns some ACAD) -- I'll go with EXEL and IDIX. Neither my Mom or I own those, and they have been beaten up with all the rest. CYTK also looks pretty cheap. Trickle pick is IVGN. But what I actually bought calls in towards the close on Friday? Is it really a biotech anymore, or a pharma . . . AMGN. I own a core position, but that was a near term trade, so maybe doesn't count (been trading AMGN calls a lot lately; I seem to have some feel for it -- though averaging in is sometimes required -- and you can't beat the liquidity (need to unload 80 calls in a minute at one price? AMGN is one of the few "biotechs" in which you can do this). Was there supposed to be a certain holding period for these picks?

Cheers, Biomaven
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext